10
Participants
Start Date
August 31, 2015
Primary Completion Date
August 31, 2017
Study Completion Date
December 31, 2017
Plasma Exchange
PLEX is a procedure in which the subject's blood is passed through a medical device which separates out plasma from the other blood components, and replaces the plasma with albumin or plasma or other colloid. PLEX therefore removes circulating pathogenic antibodies, and furthermore therapeutic benefit after PLEX supports an antibody mediated pathogenesis of disease. In PLEX, 200-250 mL plasma per kg body weight is exchanged typically over 7-14 days using 5% albumin as replacement, often at alternate days which increases the amount of immunoglobulin removed due to equilibrium effects. PLEX modality (centrifugation or filtration), type of anticoagulation, and dose scheduling will be determined by local centre practice.
Intravenous immunoglobulin
"Active Comparator: Intravenous Immunoglobulin (IVIG) IVIG is a pooled blood product from 3000-100,000 human blood donors with direct immunomodulatory effects.~IVIG will be given at a dose of 2g/kg over 4 days. Dosing at 2g/kg is established in neurological disorders, with limited evidence that lower doses are less effective although adequate dosing studies have not been performed."
University Hospitals Birmingham, Birmingham
Cambridge University Hospitals, Cambridge
Nottingham University Hospitals, Nottingham
Oxford University Hospitals, Oxford
University Hospitals Southampton, Southampton
Collaborators (1)
University of Oxford
OTHER
Stanley Medical Research Institute
OTHER
McPin Foundation
OTHER
University of Cambridge
OTHER